シスプラチン化学療法における吃逆の危険因子に関する検討
スポンサーリンク
概要
- 論文の詳細を見る
Hiccups often occur in patients receiving cisplatin (CDDP)-based chemotherapy. In the present study, we investigated the incidence of hiccups in 162 patients who received CDDP as well as risk factors for developing hiccups. Hiccups occurred in 40 (25%) of the 162 patients, and 93% were men. Twenty-six of the patients had hiccups within 48hr of CDDP, and in 31 of them the hiccups continued for between 1 and 4 days. Twenty-eight of the patients received medication (shitei-decoction, chlorpromazine, metoclopramide, etc.) to relieve hiccups, which was effective in 30% of them. Hiccups developed in patients with osteochondro sarcoma (56%), lung cancer (49%), pancreatic cancer (40%) and esophagus cancer (23%) receiving the following 4 chemotherapy regimens: CDDP+ADM+CAF (56%), CDDP+DTX (50%), CDDP+5FU (40%), and CDDP+TS 1 (20%) respectively. The CDDP dosage (mg/m^2) was higher in patients who had hiccups than in those who had none (80±22 vs 45±33, p<0.0001) and there was a positive correlation was between CDDP dosage and incidence of hiccups (p<0.001), though all patients developing them received corticosteroids and 5 HT_3 antagonists. Multiple logistic regression analysis showed that there were significant differences for the male sex (odds ratio (OR)=8, 95% CI=1.5-45.6), CDDP dose (1.03, 1.01-1.06), dexamethasone (≧16mg) (19.4, 3.9-95.2) and granisetron (6mg) (20.9, 3-143). We therefore concluded that the independent risk factors influencing the development of hiccups were the male sex and a high dose of CDDP in combination with dexamethasone (≧16mg), and granisetron (6mg).
- 2009-02-10
論文 | ランダム
- 6 Prevalence and Characteristics of Depression in Cardiovascular Patients in Japan(Is Stress a Risk of Cardiovascular Disease?,Symposium 22 (SY-22) (I),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- 17-3 ウンシュウミカン樹の落葉と枝体積含水率の変化(17.園地・施設土壌肥よく度,2008年度愛知大会)
- 2 Prognostic Factors in Patients with Coronary Artery Disease Treated with Sirolimus-eluting Stent : The HIJ-DES registry(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The J
- 2Ka13 マウスES細胞の胚様体分化に及ぼす培養面コート剤の影響(セル&ティッシュエンジニアリング,一般講演)
- 2Ka12 生理的グルコース濃度下で形成したマウスES細胞胚様体の分化的特徴(セル&ティッシュエンジニアリング,一般講演)